Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticoagulation in patients with brain cancer international registry
NL-OMON19911Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of low molecular weight heparin calcium in venous thromboembolism (VTE) and Atrial fibrillation (AFib) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Major non-traumatic intracranial hemorrhage at 12 months. Started Jan 2015; status: recruiting.
02
Drugs
low molecular weight heparin calcium
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NL-OMON19911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON19911.